前列腺癌放疗:不断演变的范式
本文以一名69岁Gleason 3+4(grade group 2)前列腺腺癌患者为例,介绍诊断与治疗挑战,回顾相关文献,并总结作者建议的管理方法,以帮助读者将关键研究结果应用于临床实践。
要点
- 病例为69岁男性,PSA从1.36 ng/mL升至5.8 ng/mL,活检示Gleason 3+4(grade group 2)腺癌。
- 影像分期CT与骨扫描未见转移证据,患者性功能良好,IPSS为6/35。
- 文章旨在结合病例综述文献,总结前列腺癌放疗的管理建议。
核心结论
- 文章通过病例展示与文献回顾,总结作者对前列腺癌放疗的管理建议,帮助读者将关键研究结果应用于临床。
研究设计与样本
- Oncology Grand Rounds系列文章,以病例展示开始,随后描述诊断与管理挑战、回顾相关文献并总结作者建议的管理方法。
主要发现
- 患者69岁,7年间PSA由1.36 ng/mL升至5.8 ng/mL,经直肠超声示37 mL腺体、无异见低回声结节。
- 活检示Gleason 3+4(grade group 2)腺癌,14针中6针阳性、17%组织受累,右尖部最大针受累80%。
- 可见神经周围侵犯,无淋巴血管侵犯,双侧底、中、尖部均有病变。
- CT腹盆腔与全身骨扫描未见转移证据;IPSS 6/35,性功能良好。
临床怎么用
- 文章旨在帮助读者理解如何将关键研究结果应用于自己临床实践中的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice. A urologist referred a 69-year-old man for a radiotherapy opinion regarding a recently diagnosed adenocarcinoma of the prostate. Annual serum prostate-specific antigen (PSA) testing over 7 years demonstrated a rise in PSA from 1.36 ng/mL to 5.8 ng/mL, prompting a transrectal ultrasound that revealed a heterogeneous 37-mL gland containing no visualized hypoechoic nodules. Biopsy disclosed a Gleason score 3+4 (grade group 2) adenocarcinoma of the prostate. The synoptic report stated that six of 14 cores and 17% of the tissue were involved, with the greatest core involvement being 80% at the right apex. Perineural invasion was present without lymphovascular invasion. Disease was present bilaterally at the base, midgland, and apex.His medical history was significant only for treated peptic ulcer disease and he was taking no medication. His International Prostate Symptom Score was six of 35, and he reported being sexually active with good erectile function. There was no family history of prostate cancer. He is retired. Digital rectal examination revealed moderate benign prostatic hypertrophy with no suspicious nodules. A staging computerized tomography (CT) scan of the abdomen and pelvis and a whole-body bone scan ordered by his referring urologist reported no evidence of metastatic disease. The patient had discussed surgical options with his urologist and now wished to consider radiotherapy approaches.
引用
- Catton CN, Lukka H, Martin J, et al. Prostate Cancer Radiotherapy: An Evolving Paradigm. J Clin Oncol. 2018. PMID: 30138084. doi:10.1200/JCO.2018.79.3257
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。